Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma Multiforme
Clinical trial NCT02078648 · COMPLETED
Trial details
- NCT number
- NCT02078648
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2017-09-01
- Enrollment
- 74
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.